androstane-3,17-diol has been researched along with Polycystic Ovarian Syndrome in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (29.63) | 18.7374 |
1990's | 12 (44.44) | 18.2507 |
2000's | 4 (14.81) | 29.6817 |
2010's | 3 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lobo, RA; Saxena, T; Stanczyk, FZ | 1 |
Carlsen, SM; Vanky, E | 1 |
Holm, G; Janson, PO; Jedel, E; Labrie, F; Lind, AK; Nilsson, L; Odén, A; Ohlsson, C; Stener-Victorin, E | 1 |
Andrico, S; Falsetti, L; Gambera, A; Sartori, E | 1 |
Tomboc, M; Witchel, SF | 1 |
Meczekalski, B; Slopien, R; Warenik-Szymankiewicz, A | 1 |
Goebelsmann, U; Horton, R; Lobo, RA | 1 |
Lobo, RA; Shoupe, D | 1 |
Kuttenn, F; Mauvais-Jarvis, P; Mowszowicz, I | 1 |
Bertoli, A; Di Daniele, N; Fusco, A; Gatti, S; Lauro, R; Magnani, A; Marini, MA | 1 |
Chang, L; Duffy, DM; Legro, RS; Lobo, RA; Stanczyk, FZ | 1 |
Carmina, E; Gentzchein, E; Lobo, RA; Stanczyk, FZ | 1 |
De Fusco, D; Falsetti, L; Rosina, B | 1 |
Diamanti-Kandarakis, E; Duleba, AJ; Mitrakou, A; Raptis, S; Tolis, G | 1 |
Hwang, YY; Roh, JS; Yoo, JB | 1 |
Diamandis, EP; Magklara, A; Obiezu, CV; Scorilas, A; Stanczyk, FZ; Thornton, MH; Wang, CY | 1 |
Kuttenn, F; Lecomte, P; Mandelbaum, J; Mauvais-Jarvis, P; Mowszowicz, I | 1 |
Carmina, E; Cassidenti, DL; Gentzschein, E; Lobo, RA; Miles, RA; Stanczyk, FZ | 1 |
Kirschner, MA; Luthold, WW; Marcondes, JA; Minnani, SL; Samojlik, E; Wajchenberg, BL | 1 |
de Rooy, HA; Ponjee, GA; Vader, HL | 1 |
Giagulli, VA; Giorgino, R; Vermeulen, A | 1 |
Blackard, WG; Clore, JN; Matt, DW; Nestler, JE; Plymate, SR; Powers, LP; Rittmaster, RS; Steingold, KA | 1 |
Connelly, JF; Davies, HE; Funder, JW; Montalto, J; Yong, AB | 1 |
Brailly, S; Couzinet, B; Le Strat, N; Schaison, G | 1 |
Lobo, RA; Serafini, P | 1 |
Franks, S; James, VH; Reed, MJ; Scanlon, MJ; Whorwood, CB | 1 |
Greep, N; Hoopes, M; Horton, R | 1 |
1 review(s) available for androstane-3,17-diol and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Hirsutism.
Topics: 17-Ketosteroids; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Cells, Cultured; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Female; Fibroblasts; Hirsutism; Humans; Liver; Male; Metabolic Clearance Rate; Ovarian Neoplasms; Polycystic Ovary Syndrome; Sebaceous Glands; Sex Hormone-Binding Globulin; Skin; Testosterone | 1981 |
4 trial(s) available for androstane-3,17-diol and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
Topics: Adult; Androgens; Androstane-3,17-diol; Estradiol; Estrone; Female; Fetal Blood; Humans; Hypoglycemic Agents; Infant, Newborn; Male; Metformin; Polycystic Ovary Syndrome; Pregnancy; Sex Hormone-Binding Globulin; Testosterone | 2010 |
Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Acneiform Eruptions; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androsterone; Combined Modality Therapy; Electroacupuncture; Exercise; Female; Humans; Hyperandrogenism; Menstrual Cycle; Motor Activity; Oligomenorrhea; Polycystic Ovary Syndrome; Severity of Illness Index; Testosterone; Time Factors; Young Adult | 2011 |
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstenedione; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Hirsutism; Humans; Luteinizing Hormone; Menstruation Disturbances; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1995 |
Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1986 |
22 other study(ies) available for androstane-3,17-diol and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Topics: Adrenal Glands; Adult; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Case-Control Studies; Dehydroepiandrosterone Sulfate; Dexamethasone; Female; Humans; Hyperandrogenism; Ovary; Polycystic Ovary Syndrome; Testosterone; Treatment Outcome | 2014 |
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Amenorrhea; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Hirsutism; Humans; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Luteinizing Hormone; Obesity; Oligomenorrhea; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography | 2002 |
Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.
Topics: Adolescent; Androstane-3,17-diol; Androstenedione; Child; Dihydrotestosterone; Female; Gene Frequency; Genotype; Glucuronosyltransferase; Heterozygote; Homozygote; Humans; Hyperandrogenism; Phenotype; Polycystic Ovary Syndrome; Puberty, Precocious; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Topics: Adolescent; Adult; Androstane-3,17-diol; Biomarkers; Body Mass Index; Case-Control Studies; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone | 2007 |
Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Androstane-3,17-diol; Androstanols; Androstenediol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone | 1983 |
The influence of androgens on insulin resistance.
Topics: Adult; Androgens; Androstane-3,17-diol; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome; Spironolactone; Testosterone | 1984 |
Metabolism of dihydrotestosterone to 5 alpha-androstane-3 alpha, 17 beta-diol glucuronide is greater in the peripheral compartment than in the splanchnic compartment.
Topics: Administration, Cutaneous; Adolescent; Adult; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Female; Hirsutism; Humans; Infusions, Intravenous; Male; Middle Aged; Polycystic Ovary Syndrome; Prospective Studies; Reference Values; Splanchnic Circulation | 1995 |
Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
Topics: Adult; Androstane-3,17-diol; Androsterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1995 |
Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.
Topics: Adolescent; Adult; Androstane-3,17-diol; Case-Control Studies; Female; Hirsutism; Humans; Hyperandrogenism; Obesity; Polycystic Ovary Syndrome | 1998 |
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1998 |
Increased peripheral androgen activity in infertile Korean women with polycystic ovaries.
Topics: Adult; Androstane-3,17-diol; Female; Humans; Infertility, Female; Korea; Luteinizing Hormone; Polycystic Ovary Syndrome; Ultrasonography | 1999 |
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
Topics: Adult; Androstane-3,17-diol; Case-Control Studies; Female; Humans; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Reference Values; Testosterone; Tissue Kallikreins | 2001 |
[12 cases of polycystic ovary type 1 (Stein-Leventhal syndrome): complete hormonal study (author's transl)].
Topics: Androstane-3,17-diol; Androstenedione; Clomiphene; Dihydrotestosterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Pregnancy; Testosterone | 1978 |
Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
Topics: Administration, Cutaneous; Adult; Androstane-3,17-diol; Androstenedione; Androsterone; Cholestenone 5 alpha-Reductase; Female; Gels; Hirsutism; Humans; Male; Oxidoreductases; Polycystic Ovary Syndrome | 1992 |
Treatment of hirsutism in women with flutamide.
Topics: Adult; Analysis of Variance; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 1992 |
Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Cyproterone; Cyproterone Acetate; Female; Hirsutism; Humans; Polycystic Ovary Syndrome | 1991 |
Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Biomarkers; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Polycystic Ovary Syndrome | 1991 |
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Diazoxide; Estradiol; Estrone; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin Resistance; Leuprolide; Obesity; Polycystic Ovary Syndrome; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 1991 |
Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
Topics: Adult; Androgens; Androstane-3,17-diol; Androstanols; Androstenediol; Androstenediols; Female; Hirsutism; Humans; In Vitro Techniques; Polycystic Ovary Syndrome; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Increased 5 alpha-reductase activity in idiopathic hirsutism.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Genitalia, Female; Hirsutism; Humans; Luteinizing Hormone; Oxidoreductases; Polycystic Ovary Syndrome; Skin; Testosterone | 1985 |
Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.
Topics: Adult; Androstane-3,17-diol; Androstanols; Body Height; Body Weight; Contraceptives, Oral; Dihydrotestosterone; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Thyroid Diseases | 1988 |
Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
Topics: Adult; Androstane-3,17-diol; Androstanols; Female; Hirsutism; Humans; Kinetics; Metabolic Clearance Rate; Polycystic Ovary Syndrome; Reference Values; Tritium | 1986 |